On the one hand it has been suggested that TLR9 may protect against obesity and the metabolic syndrome having an anti-inflammatory effect (Hong et al., 2015; Thomalla et al., 2019). Here, TLR9 is linked to obesity due to melanocortin 4 receptor deficiency.